Next Article in Journal
Straining Flow Spinning of Artificial Silk Fibers: A Review
Previous Article in Journal
Biomechanical Modeling of Prosthetic Mesh and Human Tissue Surrogate Interaction
Previous Article in Special Issue
Biosafety of Mesoporous Silica Nanoparticles
Open AccessArticle

Reprogramming Cells for Synergistic Combination Therapy with Nanotherapeutics against Uveal Melanoma

Instituto Madrileño de Estudios Avanzados en Nanociencia (IMDEA Nanociencia), Centro Nacional de Biotecnología (CNB-CSIC) Associated Unit, Faraday 9, 28049 Madrid, Spain
*
Author to whom correspondence should be addressed.
Biomimetics 2018, 3(4), 28; https://doi.org/10.3390/biomimetics3040028
Received: 6 July 2018 / Revised: 27 July 2018 / Accepted: 28 July 2018 / Published: 25 September 2018
(This article belongs to the Special Issue Selected Papers from NanoBio&Med 2017)
Uveal melanoma (UM) is the most common primary intraocular malignant tumor in adults and around half of the patients develop metastasis and die shortly after because of the lack of effective therapies for metastatic UM. Consequently, new therapeutic approaches to this disease are welcome. In this regard, microRNAs have been shown to have a key role in neoplasia progression and have the potential to be used as therapeutic tools. In addition, in different cancers including UM, a particular microRNA signature appears that is different from healthy cells. Thus, restoring the regular levels of microRNAs could restore the normal behavior of cells. In this study, four microRNAs downregulated in UM have been chosen to reprogram cancer cells, to promote cell death or increase their sensitivity to the chemotherapeutic SN38. Furthermore, to improve the internalization, stability and/or solubility of the therapeutic molecules employed in this approach, gold nanoparticles (AuNPs) were used as carriers. Remarkably, this study found a synergistic effect when the four oligonucleotides were employed and when the chemotherapeutic drug was added. View Full-Text
Keywords: uveal melanoma; microRNAs; SN38; gold nanoparticles; combination therapy uveal melanoma; microRNAs; SN38; gold nanoparticles; combination therapy
Show Figures

Graphical abstract

MDPI and ACS Style

Milán Rois, P.; Latorre, A.; Rodriguez Diaz, C.; Del Moral, Á.; Somoza, Á. Reprogramming Cells for Synergistic Combination Therapy with Nanotherapeutics against Uveal Melanoma. Biomimetics 2018, 3, 28.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop